EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY-NC 4.0

Impact of Clinicopathological and Institutional Factors on the Clinical Courses of Patients With Localized Prostate Cancer Initially Managed by Active Surveillance: An Analysis of Nationwide Real‐World Data From Japan

Mizuki Onozawa iD, Masaki Shiota iD, Taketo Kawai iD, Shinichi Sakamoto iD, Yoshiyuki Yamamoto iD, Satoru Taguchi iD, Yasuhide Kitagawa, Tohru Nakagawa iD, Shiro Hinotsu iD, Jun Miyazaki iD, Haruki Kume, Japan Study Group of Prostate Cancer (J‐CaP)

International Journal of Urology · 2026

DOI: 10.1111/iju.70642 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift International Journal of Urology, 2026. Verfasst von Mizuki Onozawa und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, International University of Health and Welfare Narita Hospital, Narita, Japan. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Watchful Waiting. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To investigate active surveillance (AS) continuation rates and associated clinical and institutional factors in Japanese patients with localized prostate cancer.

Methods

We retrospectively analyzed 989 patients with localized prostate cancer from 92 institutions who initiated AS between 2016 and 2018. Institutions were categorized into three groups based on AS uptake for low‐risk disease. Discontinuation triggers and subsequent treatments were examined.

Results

Median age was 70 years; 66.2%, 26.0%, and 7.8% of patients had low‐, intermediate‐, and high‐risk disease, respectively. Over a median follow‐up of 3.4 years, 47.0% discontinued AS (median AS continuation time: 3.0 years; 5‐year AS continuation rate: 33.7%). Multivariable analysis showed that ≥ 2 comorbidities, ≥ 3 positive biopsy cores, and T2b–c stage were associated with restricted mean continuation time differences (RMCTDs) of −0.6, −0.6, and −0.8 years, respectively (all p < 0.05). Conversely, intermediate‐ and high‐AS uptake institutions had significantly longer adjusted RMCTD (1.0 and 1.1 years, respectively; both p < 0.001). Triggers for discontinuation were more often multifaceted in high‐AS uptake institutions (39.1%) compared with low‐ or intermediate‐AS uptake institutions (16.2% and 15.1%, respectively). After discontinuation, 36.5%, 39.2%, and 24.3% of patients received prostatectomy, radiotherapy, and hormonal therapy, respectively. With advancing age, the proportion of patients whose AS was discontinued due to PSA elevation increased, as did the rate of subsequent hormonal therapy.

Conclusions

In Japanese real‐world practice, AS continuation was limited. Beyond clinicopathological factors, institutional strategies for localized prostate cancer played a significant role in treatment choices following AS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsWatchful WaitingAgedAged, 80 and overHumansMaleMiddle AgedBiopsyFollow-Up StudiesJapanNeoplasm StagingProstateProstate-Specific AntigenProstatectomyRetrospective Studies

Stichwörter der Autor:innen

active surveillance of prostate cancerdiscontinuationlocalized cancerprostate cancerreal world evidence

Substanzen

Prostate-Specific Antigen

Autor:innen und Institutionen

  • Department of Urology, International University of Health and Welfare Narita Hospital, Narita, Japan.
  • Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Department of Urology, National Center for Global Health and Medicine, Tokyo, Japan.
  • Department of Urology, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Department of Urology, Osaka University Graduate School of Medicine, Suita, Japan.
  • Department of Urology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

ORCID-Profile: Mizuki Onozawa, Masaki Shiota, Taketo Kawai, Shinichi Sakamoto, Yoshiyuki Yamamoto, Satoru Taguchi, Tohru Nakagawa, Shiro Hinotsu, Jun Miyazaki

Zitieren

APA

Onozawa, M., Shiota, M., Kawai, T., Sakamoto, S., Yamamoto, Y., Taguchi, S., Kitagawa, Y., Nakagawa, T., Hinotsu, S., Miyazaki, J., Kume, H., & Japan Study Group of Prostate Cancer (J‐CaP) (2026). Impact of Clinicopathological and Institutional Factors on the Clinical Courses of Patients With Localized Prostate Cancer Initially Managed by Active Surveillance: An Analysis of Nationwide Real‐World Data From Japan. International Journal of Urology. https://doi.org/10.1111/iju.70642

Vancouver

Onozawa M, Shiota M, Kawai T, Sakamoto S, Yamamoto Y, Taguchi S, et al. Impact of Clinicopathological and Institutional Factors on the Clinical Courses of Patients With Localized Prostate Cancer Initially Managed by Active Surveillance: An Analysis of Nationwide Real‐World Data From Japan. International Journal of Urology. 2026. doi:10.1111/iju.70642

BibTeX
@article{Onozawa2026,
  author = {Onozawa, Mizuki and Shiota, Masaki and Kawai, Taketo and Sakamoto, Shinichi and Yamamoto, Yoshiyuki and Taguchi, Satoru and Kitagawa, Yasuhide and Nakagawa, Tohru and Hinotsu, Shiro and Miyazaki, Jun and Kume, Haruki and Japan Study Group of Prostate Cancer (J‐CaP), Japan Study Group of Prostate Cancer (J‐CaP)},
  title = {Impact of Clinicopathological and Institutional Factors on the Clinical Courses of Patients With Localized Prostate Cancer Initially Managed by Active Surveillance: An Analysis of Nationwide Real‐World Data From Japan},
  journal = {International Journal of Urology},
  year = {2026},
  doi = {10.1111/iju.70642}
}
Kostenlos starten →